Health benefits will always be an investment, especially for SMB, but new options on the market can help make the investment really pay off for employees and business owners alike.

"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.

Ninety-seven percent of respondents said they'd be willing to invest time in learning a new skill.

An Illinois jury sided with drugmakers GlaxoSmithKline and Boehringer Ingelheim in the first trial over Zantac, which the FDA recalled in 2020 over claims the over-the-counter heartburn medication caused cancer.